Shiratsuchi T, Nishimori H, Ichise H, Nakamura Y, Tokino T
Laboratory of Molecular Medicine, Human Genome Center, University of Tokyo, Japan.
Cytogenet Cell Genet. 1997;79(1-2):103-8. doi: 10.1159/000134693.
We have identified two novel human genes homologous to BAI1 (brain-specific angiogenesis inhibitor 1), an angiogenesis inhibitor that is a candidate for involvement in development of glioblastoma. Like BAI1, these two genes, designated BAI2 and BAI3, were specifically expressed in brain, and are likely to be expressed in the same type of cells. However, in spite of similar tissue specificity among the three BAI genes, only BAI1 is transcriptionally regulated by p53. BAI3 expression was absent in two of nine glioblastoma cell lines examined and was significantly reduced in three of the remaining seven. These data suggest that members of this novel gene family may play important roles in suppression of glioblastoma. BAI1, BAI2 and BAI3 were mapped to 8q24, 1p35 and 6q12, respectively.
我们已经鉴定出两个与BAI1(脑特异性血管生成抑制因子1)同源的新人类基因,BAI1是一种血管生成抑制因子,可能参与胶质母细胞瘤的发生发展。与BAI1一样,这两个基因分别命名为BAI2和BAI3,在脑中特异性表达,并且可能在同一类型的细胞中表达。然而,尽管这三个BAI基因具有相似的组织特异性,但只有BAI1受p53转录调控。在所检测的9个胶质母细胞瘤细胞系中,有2个细胞系未检测到BAI3表达,其余7个细胞系中有3个细胞系BAI3表达显著降低。这些数据表明,这个新基因家族的成员可能在抑制胶质母细胞瘤中发挥重要作用。BAI1、BAI2和BAI3分别定位于8q24、1p35和6q12。